vialroom

#retatrutide 2024-10-17

Thursday19 messages4 participantstimes are UTC
Highlights from this day
  • pooled_sample — back after 10 months, has anything actually been published since 12:51
  • pooled_sample — triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history 13:18
  • meniscus_mel — the heart rate thing is real enough that i mention it whenever someone asks about starting, happy to be corrected 13:37
  • VialBot — Verification log updated: QSC — evidence added, status unchanged. 14:09
PS

back after 10 months, has anything actually been published since

site-rotation-map.png
1000 × 700 · 714 KB · not retained in the public archive
🤝14

smaller steps here

glucagon is the new bit

PS

i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps

the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial

TRIUMPH is phase 3

❤️15🤝4

the purity spread across lots worries me more than the molecule does, thats just me

why does everyone insist on smaller steps here than on the other two

triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.

mine went up too

i log resting heart rate every morning because of this and its the one number i actually watch

low and slow

VB

Verification log updated: QSC — evidence added, status unchanged.

🙏1👍9
U1

anyone stayed at 15 for months rather than climbing

MM

the half life supports weekly dosing and thats what ive done from the start, thats just me

*PeptideMeter not the other one